Overexpression and selectively regulatory roles of IL-23/IL-17 axis in the lesions of oral lichen planus

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Lu, Rui ^a,b   Zeng, Xin ^a   Han, Qi ^a   Lin, Mu ^a   Long, Long ^a   Dan, Hongxia ^a   Zhou, Gang ^b   Chen, Qianming ^a  

^a SICHUAN UNIVERSITY   (China)

^b Wuhan University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; LICHEN PLANUS; MALE; MOUTH MUCOSA; NUCLEOTIDE SEQUENCE; ORAL LICHEN PLANUS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SALIVA LEVEL; TH17 CELL; CELL CULTURE; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; METABOLISM; MIDDLE AGED;

ADULT; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; INTERLEUKIN-23; KERATINOCYTES; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED;

EID: 84904707453     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/701094     Document Type: Article

References (42)

1. Lodi G., Scully C., Carrozzo M., Griffiths M., Sugerman P. B., Thongprasom K., Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2005 100 1 40 51 2-s2.0-20444460695 10.1016/j.tripleo.2004.06.077 (Pubitemid 40813390)
2. Sugerman P. B., Savage N. W., Walsh L. J., Zhao Z. Z., Zhou X. J., Khan A., Seymour G. J., Bigby M., The pathogenesis of oral lichen planus. Critical Reviews in Oral Biology and Medicine 2002 13 4 350 365 2-s2.0-0036929027 (Pubitemid 36041624)
3. Eisen D., Carrozzo M., Sebastian J.-V. B., Thongprasom K., Number V. Oral lichen planus: clinical features and management. Oral Diseases 2005 11 6 338 349 2-s2.0-28444474150 10.1111/j.1601-0825.2005.01142.x (Pubitemid 41727231)
4. Roopashree M. R., Gondhalekar R. V., Shashikanth M. C., George J., Thippeswamy S. H., Shukla A., Pathogenesis of oral lichen planus-a review. Journal of Oral Pathology and Medicine 2010 39 10 729 734 2-s2.0-77958595691 10.1111/j.1600-0714.2010.00946.x
5. Lavanya N., Jayanthi P., Rao U., Ranganathan K., Oral lichen planus: an update on pathogenesis and treatment. Journal of Oral and Maxillofacial Pathology 2011 15 2 127 132 2-s2.0-80053496186 10.4103/0973-029X.84474
6. Carrozzo M., de Capei M. U., Dametto E., Fasano M. E., Arduino P., Broccoletti R., Vezza D., Rendine S., Curtoni E. S., Gandolfo S., Tumor necrosis factor- α and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. Journal of Investigative Dermatology 2004 122 1 87 94 2-s2.0-9144261083 10.1046/j.0022-202X.2003.22108.x (Pubitemid 38114644)
7. Yamamoto T., Osaki T., Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. Journal of Investigative Dermatology 1995 104 5 784 788 2-s2.0-0029020331
8. + T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism. American Journal of Pathology 2003 163 1 261 268 2-s2.0-0038645905 (Pubitemid 36759610)
9. Zhou G., Xia K., Du G.-F., Chen X.-M., Xu X.-Y., Lu R., Zhou H.-M., Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form. Journal of Oral Pathology and Medicine 2009 38 7 559 564 2-s2.0-70350291655 10.1111/j.1600-0714.2009.00779.x
10. Simark-Mattsson C., Bergenholtz G., Jontell M., Eklund C., Seymour G. J., Sugerman P. B., Savage N. W., Dahlgren U. I., Distribution of interleukin-2, -4, -10, tumour necrosis factor- α and transforming growth factor- β mRNAs in oral lichen planus. Archives of Oral Biology 1999 44 6 499 507 2-s2.0-0033153364 10.1016/S0003-9969(99)00013-8 (Pubitemid 29264470)
11. Khan A., Farah C. S., Savage N. W., Walsh L. J., Harbrow D. J., Sugerman P. B., Th1 cytokines in oral lichen planus. Journal of Oral Pathology and Medicine 2003 32 2 77 83 2-s2.0-0037687892 10.1034/j.1600-0714.2003.00077.x (Pubitemid 36608883)
12. Tao X.-A., Li C.-Y., Rhodus N. L., Xia J., Yang X.-P., Cheng B., Simultaneous detection of IFN-gamma and IL-4 in lesional tissues and whole unstimulated saliva from patients with oral lichen planus. Journal of Oral Pathology and Medicine 2008 37 2 83 87 2-s2.0-38149089394 10.1111/j.1600-0714. 2007.00593.x
13. Iwakura Y., Ishigame H., The IL-23/IL-17 axis in inflammation. Journal of Clinical Investigation 2006 116 5 1218 1222 2-s2.0-33646417072 10.1172/JCI28508
14. McKenzie B. S., Kastelein R. A., Cua D. J., Understanding the IL-23-IL-17 immune pathway. Trends in Immunology 2006 27 1 17 23 2-s2.0-30544436785 10.1016/j.it.2005.10.003 (Pubitemid 43083560)
15. Tan Z. Y., Bealgey K. W., Fang Y., Gong Y. M., Bao S., Interleukin-23: immunological roles and clinical implications. International Journal of Biochemistry and Cell Biology 2009 41 4 733 735 2-s2.0-59649083691 10.1016/j.biocel.2008.04.027
16. Dong C., TH17 cells in development: an updated view of their molecular identity and genetic programming. Nature Reviews Immunology 2008 8 5 337 348 2-s2.0-42649115767 10.1038/nri2295 (Pubitemid 351595217)
17. McGeachy M. J., Chen Y., Tato C. M., Laurence A., Joyce-Shaikh B., Blumenschein W. M., McClanahan T. K., O'Shea J. J., Cua D. J., The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nature Immunology 2009 10 3 314 324 2-s2.0-60749107176 10.1038/ni.1698
18. Korn T., Bettelli E., Oukka M., Kuchroo V. K., IL-17 and Th17 cells. Annual Review of Immunology 2009 27 485 517 2-s2.0-61949463911 10.1146/annurev.immunol.021908.132710
19. Boniface K., Blom B., Liu Y.-J., de Waal Malefyt R., From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunological Reviews 2008 226 1 132 146 2-s2.0-55149087226 10.1111/j.1600-065X. 2008.00714.x
20. Onishi R. M., Gaffen S. L., Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010 129 3 311 321 2-s2.0-75949102667 10.1111/j.1365-2567.2009.03240.x
21. Gaffen S. L., An overview of IL-17 function and signaling. Cytokine 2008 43 3 402 407 2-s2.0-51349111163 10.1016/j.cyto.2008.07.017
22. Toussirot É., The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflammation and Allergy: Drug Targets 2012 11 2 159 168 2-s2.0-84857774124
23. Hillyer P., Larché M. J., Bowman E. P., McClanahan T. K., de Waal Malefyt R., Schewitz L. P., Giddins G., Feldmann M., Kastelein R. A., Brennan F. M., Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis. Rheumatology 2009 48 12 1581 1589 2-s2.0-75649145666 10.1093/rheumatology/kep293
24. + T cell trafficking and development by IFN- γ: mechanism and pathological relevance in psoriasis. Journal of Immunology 2008 181 7 4733 4741 2-s2.0-58149316658
25. Larsen J. M., Bonefeld C. M., Poulsen S. S., Geisler C., Skov L., IL-23 and TH17-mediated inflammation in human allergic contact dermatitis. Journal of Allergy and Clinical Immunology 2009 123 2 486 e1 2-s2.0-59449097711 10.1016/j.jaci.2008.09.036
26. Hölttä V., Klemetti P., Sipponen T., Kociubinski G., Westerholm-Ormio M., Salo H., Räsänen L., Kolho K.-L., Färkkilä M., Savilahti E., Vaarala O., IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflammatory Bowel Diseases 2008 14 9 1175 1184 2-s2.0-54349088988 10.1002/ibd.20475
27. Geremia A., Jewell D. P., The IL-23/IL-17 pathway in inflammatory bowel disease. Expert Review of Gastroenterology and Hepatology 2012 6 2 223 237 2-s2.0-84858066817 10.1586/egh.11.107
28. Ohyama H., Kato-Kogoe N., Kuhara A., Nishimura F., Nakasho K., Yamanegi K., Yamada N., Hata M., Yamane J., Terada N., The involvement of IL-23 and the Th 17 pathway in periodontitis. Journal of Dental Research 2009 88 7 633 638 2-s2.0-68249143144 10.1177/0022034509339889
29. Lester S. R., Bain J. L., Johnson R. B., Serio F. G., Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. Journal of Periodontology 2007 78 8 1545 1550 2-s2.0-34548095351 10.1902/jop.2007.060458
30. Wang H., Luo Z., Lei L., Sun Z., Zhou M., Dan H., Zeng X., Chen Q., Interaction between oral lichen planus and chronic periodontitis with Th17-associated cytokines in serum. Inflammation 2013 36 3 696 704 2-s2.0-84877770926 10.1007/s10753-013-9594-2
31. Xie S., Ding L., Xiong Z., Zhu S., Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus. Journal of Huazhong University of Science and Technology: Medical Science 2012 32 3 451 457 2-s2.0-84865578353 10.1007/s11596-012-0078-7
32. van der Meij E. H., Mast H., van der Waal I., The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncology 2007 43 8 742 748 2-s2.0-34547909623 10.1016/j.oraloncology.2006.09.006 (Pubitemid 47259439)
33. Xiong H., Wei L., Peng B., Immunohistochemical localization of IL-17 in induced rat periapical lesions. Journal of Endodontics 2009 35 2 216 220 2-s2.0-58249104264 10.1016/j.joen.2008.10.022
34. Piskin G., Sylva-Steenland R. M. R., Bos J. D., Teunissen M. B. M., In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. Journal of Immunology 2006 176 3 1908 1915 2-s2.0-31144441631 (Pubitemid 43134336)
35. Zhu S., Qian Y., IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clinical Science 2012 122 11 487 511 2-s2.0-84860238945 10.1042/CS20110496
36. Piccinni M.-P., Lombardelli L., Logiodice F., Tesi D., Kullolli O., Biagiotti R., Giudizi M., Romagnani S., Maggi E., Ficarra G., Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Diseases 2014 20 2 212 218 2-s2.0-84875845038 10.1111/odi.12094
37. Chung Y., Dong C., Don't leave home without it: the IL-23 visa to TH-17 cells. Nature Immunology 2009 10 3 236 238 2-s2.0-60749091132 10.1038/ni0309-236
38. + T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. Journal of Allergy and Clinical Immunology 2007 119 5 1218 1224 2-s2.0-34247552894 10.1016/j.jaci.2007.01.010 (Pubitemid 46667160)
39. Ichimura M., Hiratsuka K., Ogura N., Utsunomiya T., Sakamaki H., Kondoh T., Abiko Y., Otake S., Yamamoto M., Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. Journal of Oral Pathology and Medicine 2006 35 3 167 174 2-s2.0-33645243665 10.1111/j.1600-0714.2006.00402.x
40. Abiko Y., Jinbu Y., Noguchi T., Nishimura M., Kusano K., Amaratunga P., Shibata T., Kaku T., Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. An immunohistochemical study. Pathology Research and Practice 2002 198 8 537 542 2-s2.0-0036390959
41. Nishimura M., Abiko Y., Kusano K., Yamazaki M., Saitoh M., Mizoguchi I., Jinbu Y., Noguchi T., Kaku T., Localization of human β -defensin 3 mRNA in normal oral epithelium, leukoplakia, and lichen planus: an in situ hybridization study. Medical Electron Microscopy 2003 36 2 94 97 2-s2.0-0042371615 (Pubitemid 36903230)
42. Dong C., IL-23/IL-17 biology and therapeutic considerations. Journal of Immunotoxicology 2008 5 1 43 46 2-s2.0-41149106394 10.1080/15476910801897953 (Pubitemid 351431258)